BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Imaging biomarkers in Alzheimer's Disease: the technical and regul
 atory challenges of global deployment - Hill\, D (IXICO and University Col
 lege London)
DTSTART:20110823T143000Z
DTEND:20110823T150000Z
UID:TALK32479@talks.cam.ac.uk
CONTACT:Mustapha Amrani
DESCRIPTION:Drug development involves huge and extremely expensive global 
 experiments\, which at late phase can involve many thousands of patients r
 ecruited at 100s of hospitals all over the world.  Imaging biomarkers have
  the potential to provide standardized\, quantitative measurements of pati
 ent eligibility for the study\,  drug side effects\, and drug efficacy\, b
 ut deploying them in such global studies has great challenges. Alzheimer's
  Disease (AD) is an area of huge unmet medical need\, and huge sums are be
 ing invested in testing potential new treatments for AD\, and drug compani
 es are being very ambitious in their use of sophisticated image analysis m
 ethods in these studies. The technical and regulatory challenges of these 
 applications is quite different from the normal focus of image analysis re
 search\, but the potential benefit of overcoming these challenges is bette
 r tools to help bring safe and effective medicines to patients.\n
LOCATION:Seminar Room 1\, Newton Institute
END:VEVENT
END:VCALENDAR